protein kinase B inhibitors (Teva)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameprotein kinase B inhibitors (Teva)
Drug Alias NameProtein kinase B inhibitor (DeveloGen)protein kinase B inhibitor (Peptor)NL-71-101PTR-6320
ClassificationSmall molecules
Mechanisms of ActionProto-oncogene proteins c-akt inhibitorsAnticancer protein kinase inhibitors
TargetsProto-oncogene proteins c-akt
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPeptor Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPeptor LtdTeva Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A